| Cat. No. | Product Name | Information | 
            
                
            	| PC-24508 | Balinatunfib TNFR1 inhibitor | Balinatunfib (SAR441566) is a potent, oral inhibitor of tumor necrosis factor receptor 1 (TNFR1) signaling, binds to human TNF with SPR Kd of 15.1 nM. | 
            
                
            	| PC-21382 | SB-U015 TRAP1 inhibitor | SB-U015 is a MitoQ derivative and tumor necrosis factor receptor-associated protein 1 (TRAP1) inhibitor. | 
            
                
            	| PC-21380 | SMTIN-C10 TRAP1 inhibitor | SMTIN-C10 is a potent, allosteric tumor necrosis factor receptor-associated protein-1 (TRAP1) inhibitor with IC50 of 1.88 uM, by conjugating TPP a C10 linker, and PU-H71. | 
            
                
            	| PC-20658 | Liquidambaric acid TRAF2 inhibitor | Liquidambaric acid (Betulonic acid) ia a natural compound inhibiting oncogenic Wnt/β-catenin signaling in vitro and in vivo, directly targets tumor necrosis factor receptor-associated factor 2 (TRAF2) with Kd of 6.02 uM in MST assays. | 
            
                
            	| PC-73214 | UCB-9260 TNF inhibitor | UCB-9260 is a specific, orally active compound, inhibits tumour necrosis factor (TNF) signaling by stabilising an asymmetric form of the trimer, binds to TNF with Kd of 13 nM. | 
            
                
            	| PC-35450 | Foslinanib TRAP1 inhibitor | Foslinanib (TRX-818, CVM-1118) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1. | 
            
                
            	| PC-22719 | R-7050 TNFR inhibitor | R-7050 is a specific small molecule TNF-alpha receptor (TNFR) antagonist with EC50 of 0.63 uM for TNFα-induced ICAM-1 expression inhibition, shows greater selectivity toward TNFα. | 
            
                
            	| PC-22074 | TNFR1 inhibitor FKC TNFR1 inhibitor | TNFR1 inhibitor FKC is an allosteric inhibitor targets TNFR1 (Tumor necrosis factor receptor 1), inhibits TNFR1 activation by altering the conformational states of the receptor dimer without blocking receptor-ligand interaction or disrupting receptor dimerization. |